Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

  1. OncologyPRO
  2. Meeting resources
  3. ESMO Gynaecological Cancers Congress-2021

Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next?

The evolving role of molecular profiling for therapeutic stratification in newly diagnosed ovarian cancer

Date

25 Jun 2021

Session

Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next?

Topics

Tumour Site

Ovarian Cancer

Presenters

David SP Tan

Authors

D.S. Tan

Author affiliations

  • NUS-National University of Singapore-National University Health System (NUHS), 119228 - Singapore/SG
More

Resources

Login to access the resources on OncologyPRO.

Login

Resources from the same session

Live Q&A and discussion

Presenter: All Speakers

Session: Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.